Editorial: Upadacitinib in Perianal Crohn's Disease
Alimentary Pharmacology & Therapeutics · 2026-08 · 64 (4) · 544-545
DOI: 10.1111/apt.70759 ↗At a glance
Editorial in Alimentary Pharmacology & Therapeutics, published online on 2026-06-02. Written by Manjeet Kumar Goyal and 1 co-authors. Institution: Department of Internal Medicine, Cleveland Clinic Akron General, Akron, Ohio, USA. Cited 1 times so far (Crossref); 10 references. The full text is freely available in PubMed Central.
Abstract (original language)
Intet abstract tilgængeligt.
Authors and institutions
- Department of Internal Medicine, Cleveland Clinic Akron General, Akron, Ohio, USA.
- Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, USA.
ORCID profiles: Shrinivas Bishu
Cite
APA
Goyal, M. K., & Bishu, S. (2026). Editorial: Upadacitinib in Perianal Crohn's Disease. Alimentary Pharmacology & Therapeutics, 64(4), 544-545. https://doi.org/10.1111/apt.70759
Vancouver
Goyal MK, Bishu S. Editorial: Upadacitinib in Perianal Crohn's Disease. Alimentary Pharmacology & Therapeutics. 2026;64(4):544-545. doi:10.1111/apt.70759
BibTeX
@article{Goyal2026,
author = {Goyal, Manjeet Kumar and Bishu, Shrinivas},
title = {Editorial: Upadacitinib in Perianal Crohn's Disease},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {64},
number = {4},
pages = {544--545},
doi = {10.1111/apt.70759}
}
EUVIMED